BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16177225)

  • 1. POLG mutations in Alpers syndrome.
    Nguyen KV; Østergaard E; Ravn SH; Balslev T; Danielsen ER; Vardag A; McKiernan PJ; Gray G; Naviaux RK
    Neurology; 2005 Nov; 65(9):1493-5. PubMed ID: 16177225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POLG1 mutations associated with progressive encephalopathy in childhood.
    Kollberg G; Moslemi AR; Darin N; Nennesmo I; Bjarnadottir I; Uvebrant P; Holme E; Melberg A; Tulinius M; Oldfors A
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):758-68. PubMed ID: 16896309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis of Alpers syndrome.
    Nguyen KV; Sharief FS; Chan SS; Copeland WC; Naviaux RK
    J Hepatol; 2006 Jul; 45(1):108-16. PubMed ID: 16545482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus.
    Uusimaa J; Hinttala R; Rantala H; Päivärinta M; Herva R; Röyttä M; Soini H; Moilanen JS; Remes AM; Hassinen IE; Majamaa K
    Epilepsia; 2008 Jun; 49(6):1038-45. PubMed ID: 18294203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POLG mutations and Alpers syndrome.
    Davidzon G; Mancuso M; Ferraris S; Quinzii C; Hirano M; Peters HL; Kirby D; Thorburn DR; DiMauro S
    Ann Neurol; 2005 Jun; 57(6):921-3. PubMed ID: 15929042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion.
    Naviaux RK; Nguyen KV
    Ann Neurol; 2004 May; 55(5):706-12. PubMed ID: 15122711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POLG exon 22 skipping induced by different mechanisms in two unrelated cases of Alpers syndrome.
    Mousson de Camaret B; Chassagne M; Mayençon M; Padet S; Crehalet H; Clerc-Renaud P; Rouvet I; Zabot MT; Rivier F; Sarda P; des Portes V; Bozon D
    Mitochondrion; 2011 Jan; 11(1):223-7. PubMed ID: 20691285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapidly progressive neurological deterioration in a child with Alpers syndrome exhibiting a previously unremarkable brain MRI.
    Brunetti-Pierri N; Selby K; O'Sullivan M; Hendson G; Truong C; Waters PJ; Wong LJ
    Neuropediatrics; 2008 Jun; 39(3):179-83. PubMed ID: 18991199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound heterozygous polymerase gamma gene mutation in a patient with Alpers disease.
    Cardenas JF; Amato RS
    Semin Pediatr Neurol; 2010 Mar; 17(1):62-4. PubMed ID: 20434700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features.
    Wolf NI; Rahman S; Schmitt B; Taanman JW; Duncan AJ; Harting I; Wohlrab G; Ebinger F; Rating D; Bast T
    Epilepsia; 2009 Jun; 50(6):1596-607. PubMed ID: 19054397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel POLG gene mutation in 4 children with Alpers-like hepatocerebral syndromes.
    Kurt B; Jaeken J; Van Hove J; Lagae L; Löfgren A; Everman DB; Jayakar P; Naini A; Wierenga KJ; Van Goethem G; Copeland WC; DiMauro S
    Arch Neurol; 2010 Feb; 67(2):239-44. PubMed ID: 20142534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mono-allelic POLG expression resulting from nonsense-mediated decay and alternative splicing in a patient with Alpers syndrome.
    Chan SS; Longley MJ; Naviaux RK; Copeland WC
    DNA Repair (Amst); 2005 Dec; 4(12):1381-9. PubMed ID: 16181814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile Alpers disease.
    Wiltshire E; Davidzon G; DiMauro S; Akman HO; Sadleir L; Haas L; Zuccollo J; McEwen A; Thorburn DR
    Arch Neurol; 2008 Jan; 65(1):121-4. PubMed ID: 18195149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional defects due to spacer-region mutations of human mitochondrial DNA polymerase in a family with an ataxia-myopathy syndrome.
    Luoma PT; Luo N; Löscher WN; Farr CL; Horvath R; Wanschitz J; Kiechl S; Kaguni LS; Suomalainen A
    Hum Mol Genet; 2005 Jul; 14(14):1907-20. PubMed ID: 15917273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpers syndrome with mutations in POLG: clinical and investigative features.
    Hunter MF; Peters H; Salemi R; Thorburn D; Mackay MT
    Pediatr Neurol; 2011 Nov; 45(5):311-8. PubMed ID: 22000311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion.
    Naviaux RK; Nguyen KV
    Ann Neurol; 2005 Sep; 58(3):491. PubMed ID: 16130100
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenotypic and genotypic variability in Alpers syndrome.
    Sofou K; Moslemi AR; Kollberg G; Bjarnadóttir I; Oldfors A; Nennesmo I; Holme E; Tulinius M; Darin N
    Eur J Paediatr Neurol; 2012 Jul; 16(4):379-89. PubMed ID: 22237560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases.
    Tzoulis C; Engelsen BA; Telstad W; Aasly J; Zeviani M; Winterthun S; Ferrari G; Aarseth JH; Bindoff LA
    Brain; 2006 Jul; 129(Pt 7):1685-92. PubMed ID: 16638794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial status epilepticus - rapid genetic diagnosis of Alpers' disease.
    McCoy B; Owens C; Howley R; Ryan S; King M; Farrell MA; Lynch BJ
    Eur J Paediatr Neurol; 2011 Nov; 15(6):558-62. PubMed ID: 21704543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr?
    Neeve VC; Samuels DC; Bindoff LA; van den Bosch B; Van Goethem G; Smeets H; Lombès A; Jardel C; Hirano M; Dimauro S; De Vries M; Smeitink J; Smits BW; de Coo IF; Saft C; Klopstock T; Keiling BC; Czermin B; Abicht A; Lochmüller H; Hudson G; Gorman GG; Turnbull DM; Taylor RW; Holinski-Feder E; Chinnery PF; Horvath R
    Brain; 2012 Dec; 135(Pt 12):3614-26. PubMed ID: 23250882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.